ARRA's Impact on e-Prescribing

On March 16, Reuters reported the results of a study analyzing the impact of the stimulus package on e-Prescribing. The study predicts that e-prescribing utilization will almost double in five years, compared to what it would have been without ARRA (the Amercian Recovery and Reinvestment Act of 2009).

The study forecasts a striking reduction in adverse drug events of over 3.5 million in 5 years and a half million reduction in hospitalizations. Total savings are forecast to be $56 billion, including federal government savings of $22 billion.

The study was sponsored by an interested party (PCMA) and conducted by Visante.